EP0983091A4 - Formulierungen auf der basis des proteins für fettleibigkeit - Google Patents

Formulierungen auf der basis des proteins für fettleibigkeit

Info

Publication number: EP0983091A4
Authority: EP; European Patent Office
Prior art keywords: protein formulations; obesity protein; obesity; formulations; protein
Prior art date: 1997-01-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP98902573A

Other languages

English (en)

French (fr)

Other versions

EP0983091A1 (de

Inventor

Joseph V Rinella Jr

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Eli Lilly and Co

Original Assignee

Eli Lilly and Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1997-01-17

Filing date

1998-01-16

Publication date

2002-04-10

1998-01-16 Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co

2000-03-08 Publication of EP0983091A1 publication Critical patent/EP0983091A1/de

2002-04-10 Publication of EP0983091A4 publication Critical patent/EP0983091A4/de

Status Withdrawn legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2264—Obesity-gene products, e.g. leptin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/5759—Products of obesity genes, e.g. leptin, obese (OB), tub, fat

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Obesity (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Child & Adolescent Psychology (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Genetics & Genomics (AREA)
Endocrinology (AREA)
Zoology (AREA)
Hematology (AREA)
Immunology (AREA)
Diabetes (AREA)
Epidemiology (AREA)
Toxicology (AREA)
Biochemistry (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

EP98902573A 1997-01-17 1998-01-16 Formulierungen auf der basis des proteins für fettleibigkeit Withdrawn EP0983091A4 (de)

Applications Claiming Priority (7)

Application Number	Priority Date	Filing Date	Title
US3571597P	1997-01-17	1997-01-17
US35715P		1997-01-17
US5496997P	1997-08-07	1997-08-07
US54969P		1997-08-07
US6535297P	1997-11-12	1997-11-12
US65352P		1997-11-12
PCT/US1998/000816 WO1998031390A1 (en)	1997-01-17	1998-01-16	Obesity protein formulations

Publications (2)

Publication Number	Publication Date
EP0983091A1 EP0983091A1 (de)	2000-03-08
EP0983091A4 true EP0983091A4 (de)	2002-04-10

Family

ID=27364892

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP98902573A Withdrawn EP0983091A4 (de)	1997-01-17	1998-01-16	Formulierungen auf der basis des proteins für fettleibigkeit

Country Status (5)

Country	Link
EP (1)	EP0983091A4 (de)
JP (1)	JP2001511180A (de)
AU (1)	AU5919998A (de)
CA (1)	CA2277282A1 (de)
WO (1)	WO1998031390A1 (de)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996031526A1 (en) *	1995-04-06	1996-10-10	Amylin Pharmaceuticals, Inc.	Anti-obesity agents
EP0797999A2 (de) *	1996-03-26	1997-10-01	Eli Lilly And Company	Fettleibigkeitprotein-Formulierungen
EP0827750A2 (de) *	1996-08-23	1998-03-11	Eli Lilly And Company	Formulierungen des Obesitäts-Proteins

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI973162L (fi) *	1995-01-31	1997-09-30	Lilly Co Eli	Liikalihavuutta vastustavia proteiineja
US6165981A (en) *	1995-03-07	2000-12-26	Dade Behring Inc.	Stabilizing solutions for proteins and peptides
GB9509164D0 (en) *	1995-05-05	1995-06-28	Smithkline Beecham Plc	Novel compounds

1998
- 1998-01-16 CA CA002277282A patent/CA2277282A1/en not_active Abandoned
- 1998-01-16 EP EP98902573A patent/EP0983091A4/de not_active Withdrawn
- 1998-01-16 JP JP53454298A patent/JP2001511180A/ja active Pending
- 1998-01-16 AU AU59199/98A patent/AU5919998A/en not_active Abandoned
- 1998-01-16 WO PCT/US1998/000816 patent/WO1998031390A1/en not_active Ceased

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1996031526A1 (en) *	1995-04-06	1996-10-10	Amylin Pharmaceuticals, Inc.	Anti-obesity agents
EP0797999A2 (de) *	1996-03-26	1997-10-01	Eli Lilly And Company	Fettleibigkeitprotein-Formulierungen
EP0827750A2 (de) *	1996-08-23	1998-03-11	Eli Lilly And Company	Formulierungen des Obesitäts-Proteins

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9831390A1 *

Also Published As

Publication number	Publication date
JP2001511180A (ja)	2001-08-07
AU5919998A (en)	1998-08-07
WO1998031390A1 (en)	1998-07-23
EP0983091A1 (de)	2000-03-08
CA2277282A1 (en)	1998-07-23

Legal Events

Date	Code	Title	Description
2000-01-21	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2000-03-08	17P	Request for examination filed	Effective date: 19990715
2000-03-08	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI NL PT SE
2002-04-10	A4	Supplementary search report drawn up and despatched	Effective date: 20020227
2002-04-10	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LI NL PT SE
2002-04-10	RIC1	Information provided on ipc code assigned before grant	Free format text: 7A 61K 38/22 A, 7C 07K 14/575 B
2002-11-29	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2003-01-08	18D	Application deemed to be withdrawn	Effective date: 20020517
2003-01-15	R18D	Application deemed to be withdrawn (corrected)	Effective date: 20020517

Publication	Publication Date	Title
EG23685A (en)	2007-05-09	Activated protein c formulations
EP1113799A4 (de)	2004-06-09	Proteinformulierung
GB9719879D0 (en)	1997-11-19	Protein
GB9703681D0 (en)	1997-04-09	Protein complemention
AU1750997A (en)	1997-08-11	Obesity protein formulations
EP1151006A4 (de)	2002-07-24	Menschlicher an ein g-protein gekoppelter rezeptor
AU1705197A (en)	1997-08-11	Obesity protein formulations
GB9715064D0 (en)	1997-09-24	Protein expression
PL344979A1 (en)	2001-11-19	Angiostatin-binding protein
GB9700154D0 (en)	1997-02-26	Peptides
AU2243997A (en)	1997-08-11	Obesity protein formulations
ZA984322B (en)	1999-01-19	Sucrose-binding proteins
AU1747297A (en)	1997-08-11	Obesity protein formulations
GB9720784D0 (en)	1997-12-03	Protein
GB9828880D0 (en)	1999-02-17	Protein
AU6569998A (en)	1998-10-12	Obesity protein formulations
GB9827016D0 (en)	1999-02-03	Receptor protein
EP0983091A4 (de)	2002-04-10	Formulierungen auf der basis des proteins für fettleibigkeit
EP0971742A4 (de)	2002-04-10	Fettsuchtprotein formulierungen
GB9602409D0 (en)	1996-04-03	Obesity protein formulations
GB9602408D0 (en)	1996-04-03	Obesity protein formulations
GB9602406D0 (en)	1996-04-03	Obesity protein formulations
GB9602410D0 (en)	1996-04-03	Obesity protein formulations
GB9819038D0 (en)	1998-10-28	Protein
GB9812607D0 (en)	1998-08-12	Protein